HROWL
Income statement / Annual
Last year (2023), Harrow Health, Inc. 8.625% Senior Notes due 2026's total revenue was $130.19 M,
an increase of 46.95% from the previous year.
In 2023, Harrow Health, Inc. 8.625% Senior Notes due 2026's net income was -$24.41 M.
See Harrow Health, Inc. 8.625% Senior Notes due 2026,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$130.19 M
|
$88.60 M
|
$72.48 M
|
$48.87 M
|
$51.17 M
|
$41.37 M
|
$26.77 M
|
$19.94 M
|
$9.72 M
|
$1.66 M
|
| Cost of Revenue |
$39.64 M |
$25.38 M |
$18.21 M |
$14.46 M |
$16.75 M |
$16.52 M |
$13.51 M |
$9.83 M |
$5.21 M |
$1.09 M |
| Gross Profit |
$90.55 M |
$63.21 M |
$54.26 M |
$34.41 M |
$34.42 M |
$24.85 M |
$13.27 M |
$10.11 M |
$4.51 M |
$567,407.00 |
| Gross Profit Ratio |
0.7 |
0.71 |
0.75 |
0.7 |
0.67 |
0.6 |
0.5 |
0.51 |
0.46 |
0.34 |
| Research and Development
Expenses |
$6.65 M
|
$3.05 M
|
$11.08 M
|
$2.41 M
|
$2.08 M
|
$825,000.00
|
$413,000.00
|
$739,000.00
|
$332,000.00
|
$236,660.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$17.96 M
|
$17.57 M
|
$12.50 M
|
$8.09 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.06 M
|
$7.38 M
|
$6.50 M
|
$2.39 M
|
| Selling, General &
Administrative Expenses |
$83.09 M
|
$58.24 M
|
$41.32 M
|
$31.25 M
|
$33.10 M
|
$29.24 M
|
$25.02 M
|
$24.95 M
|
$19.00 M
|
$10.48 M
|
| Other Expenses |
$380,000.00 |
-$15.93 M |
-$19.49 M |
-$3.80 M |
$630,000.00 |
$103,000.00 |
$0.00 |
$1.54 M |
$31,000.00 |
$0.00 |
| Operating Expenses |
$90.12 M |
$61.29 M |
$52.40 M |
$33.66 M |
$35.18 M |
$30.07 M |
$25.43 M |
$25.69 M |
$19.33 M |
$10.71 M |
| Cost And Expenses |
$129.76 M |
$86.68 M |
$70.61 M |
$48.12 M |
$51.93 M |
$46.59 M |
$38.94 M |
$35.52 M |
$24.54 M |
$11.81 M |
| Interest Income |
$0.00 |
$7.24 M |
$5.44 M |
$2.24 M |
$0.00 |
$0.00 |
$0.00 |
$10,000.00 |
$13,000.00 |
$32,446.00 |
| Interest Expense |
$21.32 M |
$7.24 M |
$5.44 M |
$2.24 M |
$2.50 M |
$2.73 M |
$3.03 M |
$6.00 M |
$1.12 M |
$3,800.00 |
| Depreciation &
Amortization |
$12.34 M
|
$3.67 M
|
$2.40 M
|
$2.74 M
|
$2.66 M
|
$1.84 M
|
$1.77 M
|
$1.41 M
|
$610,000.00
|
$85,349.00
|
| EBITDA |
$9.72 M
|
-$3.20 M
|
-$10.14 M
|
$3.49 M
|
$1.44 M
|
-$2.73 M
|
-$10.40 M
|
-$14.06 M
|
-$14.21 M
|
-$10.06 M
|
| EBITDA Ratio |
0.07 |
0.02 |
0.03 |
0.02 |
0.04 |
-0.07 |
-0.56 |
-0.59 |
-1.46 |
-6.04 |
| Operating Income Ratio
|
0
|
-0.02
|
-0
|
-0.03
|
-0.01
|
-0.13
|
-0.45
|
-0.8
|
-1.53
|
-6.11
|
| Total Other
Income/Expenses Net |
-$24.14 M
|
-$15.93 M
|
-$19.49 M
|
-$3.80 M
|
$386,000.00
|
$19.84 M
|
-$757,000.00
|
-$3.32 M
|
-$1.08 M
|
$28,646.00
|
| Income Before Tax |
-$23.71 M |
-$14.01 M |
-$17.87 M |
-$3.42 M |
-$125,000.00 |
$14.63 M |
-$12.92 M |
-$19.20 M |
-$15.90 M |
-$10.12 M |
| Income Before Tax Ratio
|
-0.18
|
-0.16
|
-0.25
|
-0.07
|
-0
|
0.35
|
-0.48
|
-0.96
|
-1.64
|
-6.09
|
| Income Tax Expense |
$701,000.00 |
$75,000.00 |
$133,000.00 |
$4,000.00 |
$2.47 M |
-$19.45 M |
-$935,000.00 |
-$111,000.00 |
$1.08 M |
-$28,646.00 |
| Net Income |
-$24.41 M |
-$14.09 M |
-$18.01 M |
-$3.42 M |
-$2.59 M |
$14.63 M |
-$11.99 M |
-$19.09 M |
-$15.90 M |
-$10.12 M |
| Net Income Ratio |
-0.19 |
-0.16 |
-0.25 |
-0.07 |
-0.05 |
0.35 |
-0.45 |
-0.96 |
-1.64 |
-6.09 |
| EPS |
-0.75 |
-0.51 |
-0.67 |
-0.13 |
-0.1 |
0.61 |
-0.6 |
-1.5 |
-1.66 |
-1.11 |
| EPS Diluted |
-0.75 |
-0.51 |
-0.67 |
-0.13 |
-0.0979 |
0.61 |
-0.6 |
-1.5 |
-1.66 |
-1.11 |
| Weighted Average Shares
Out |
$32.62 M
|
$27.46 M
|
$26.76 M
|
$25.90 M
|
$25.32 M
|
$23.81 M
|
$19.98 M
|
$12.74 M
|
$9.58 M
|
$9.13 M
|
| Weighted Average Shares
Out Diluted |
$32.62 M
|
$27.46 M
|
$26.76 M
|
$25.90 M
|
$26.47 M
|
$23.81 M
|
$20.03 M
|
$12.74 M
|
$9.58 M
|
$9.13 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
